AstraZeneca PLC
NASDAQ:AZN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
61.03
87.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Revenue Breakdown
Breakdown by Geography
AstraZeneca PLC
|
Total Revenue:
45.8B
USD
|
|
The Americas:
20.8B
USD
|
|
Asia, Africa And Australasia:
11.9B
USD
|
|
Europe:
9.7B
USD
|
|
China:
5.9B
USD
|
|
Japan:
3.6B
USD
|
|
Uk:
3.4B
USD
|
|
Other, Europe:
3.1B
USD
|
|
Sweden:
1.7B
USD
|
|
France:
1.2B
USD
|
|
Canada:
967m
USD
|
|
Spain:
847m
USD
|
|
Italy:
813m
USD
|
|
Australia:
390m
USD
|
Breakdown by Segments
AstraZeneca PLC
|
Total Revenue:
45.8B
USD
|
|
Total Oncology:
17.1B
USD
|
|
Cvrm:
10.6B
USD
|
|
Rare Disease:
7.8B
USD
|
|
Farxiga:
6B
USD
|
|
Tagrisso:
5.8B
USD
|
|
Imfinzi:
4.2B
USD
|
|
Soliris:
3.1B
USD
|
|
Ultomiris:
3B
USD
|
|
Lynparza:
2.8B
USD
|
|
Calquence:
2.5B
USD
|
|
Symbicort:
2.4B
USD
|
|
Fasenra:
1.6B
USD
|
|
Brilinta:
1.3B
USD
|
|
Total Other Medicines:
1.2B
USD
|
|
Strensiq:
1.2B
USD
|
|
Crestor:
1.1B
USD
|
|
Enhertu:
1B
USD
|
|
Zoladex:
952m
USD
|
|
Nexium:
945m
USD
|
|
Pulmicort:
713m
USD
|
|
Breztri:
677m
USD
|
|
Seloken/Toprol-Xl:
640m
USD
|
|
Synagis:
546m
USD
|
|
Lokelma:
412m
USD
|
|
Koselugo:
331m
USD
|
|
Faslodex:
297m
USD
|
|
Saphnelo:
280m
USD
|
|
Roxadustat:
271m
USD
|
|
Other, Others:
231m
USD
|
|
Onglyza:
227m
USD
|
|
Oncology, Others:
224m
USD
|
|
Flumist:
216m
USD
|
|
Andexxa:
182m
USD
|
|
Kanuma:
171m
USD
|
|
Bydureon:
163m
USD
|
|
Bevespi:
58m
USD
|
|
Daliresp/Daxas:
54m
USD
|
|
Vaxzevria:
12m
USD
|
You don't have any saved screeners yet
